St. Jude Medical Obtains Foreign Antitrust Clearance To Acquire Advanced Neuromodulation Systems
Published: Nov 11, 2005
ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 11, 2005--St. Jude Medical, Inc. (NYSE:STJ) announced today that the German Federal Cartel Office confirmed that the acquisition of Advanced Neuromodulation Systems, Inc. (NASDAQ:ANSI) by St. Jude Medical may be completed. This approval, together with the previously announced expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, satisfies the antitrust approval condition set forth in the parties' merger agreement. No other regulatory approvals are required for the merger.